SEC Form D · filed February 19, 2021
Processa Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (26)
Sian W. Bigora · Hanover, MDExecVirgil W. Thompson · Hanover, MDDirectorWendy W. Guy · Hanover, MDExecDavid Young · Hanover, MDExec · DirectorPatrick Lin · Hanover, MDExecJustin W. Yorke · Hanover, MDDirectorGeraldine W. Pannu · Hanover, MDDirectorEagle Point Global Management GP, LLC · Seattle, WADirectorEagle Point Global Management, LP · Seattle, WAExecAnthony M. Leach · San Francisco, CAExecDerek A. Reisfield · Sunnyvale, CADirectorRichard A. Cohen · Sunnyvale, CAExecMark F. Van Coeverden De Groot · Toronto, Ontario, CanadaExec · DirectorMichael W. Floyd · Hanover, MDExecKhalid W. Islam · Hanover, MDDirectorJames W. Stanker · Hanover, MDExecBrian Cassidy · New York, NYExecStephen Tiller · New York, NYDirectorGregory J. Smith · New York, NYExec · DirectorClifford T. Bengis · Seattle, WAExecJaetaek J. Yang · Seattle, WADirectorStephanie Whalen · Silver Spring, MDExecMichael W. Floyd · Hanover, MDExecKhalid W. Islam · Hanover, MDDirectorGeraldine W. Pannu · Hanover, MDDirectorJames W. Stanker · Hanover, MDExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗